Molecure S.A. (WSE:MOC)
Poland · Delayed Price · Currency is PLN 5.70
+0.22 (4.01%)
Jun 12, 2026, 5:03 PM CET
Molecure Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 6.52 | 2.17 | 3.65 | 7.51 | 1.17 |
Other Revenue | - | 0.74 | - | - | - |
| 6.52 | 2.92 | 3.65 | 7.51 | 1.17 | |
Revenue Growth (YoY) | 123.34% | -20.08% | -51.39% | 543.32% | -99.06% |
Cost of Revenue | 23.08 | 3.41 | 4.1 | 5.06 | 2.77 |
Gross Profit | -16.56 | -0.49 | -0.45 | 2.45 | -1.61 |
Selling, General & Admin | - | 23.02 | 26.88 | 34.39 | 8.99 |
Other Operating Expenses | - | 0.93 | 0.92 | 1.31 | 0.03 |
Operating Expenses | - | 31.81 | 31.68 | 40.12 | 12.16 |
Operating Income | -16.56 | -32.3 | -32.13 | -37.67 | -13.76 |
Interest Expense | - | -0.05 | -0.09 | -0.02 | -0.01 |
Interest & Investment Income | - | 1.13 | 4.39 | 1.91 | 0 |
Currency Exchange Gain (Loss) | - | -0.02 | -0.54 | -0.07 | 0.13 |
Other Non Operating Income (Expenses) | 0.87 | -0.05 | -0 | -0.1 | -0 |
EBT Excluding Unusual Items | -15.69 | -31.29 | -28.37 | -35.95 | -13.64 |
Pretax Income | -15.69 | -31.29 | -28.37 | -35.95 | -13.64 |
Net Income | -15.69 | -31.29 | -28.37 | -35.95 | -13.64 |
Net Income to Common | -15.69 | -31.29 | -28.37 | -35.95 | -13.64 |
Shares Outstanding (Basic) | 21 | 20 | 17 | 14 | 14 |
Shares Outstanding (Diluted) | 21 | 20 | 17 | 14 | 14 |
Shares Change (YoY) | 1.98% | 20.00% | 20.00% | 0.56% | 2.58% |
EPS (Basic) | -0.76 | -1.55 | -1.69 | -2.56 | -0.98 |
EPS (Diluted) | -0.76 | -1.55 | -1.69 | -2.56 | -0.98 |
Free Cash Flow | -2,029 | -57.65 | -23.65 | -37.45 | -15.95 |
Free Cash Flow Per Share | -98.47 | -2.85 | -1.41 | -2.67 | -1.14 |
Gross Margin | -253.98% | -16.78% | -12.29% | 32.64% | -137.47% |
Operating Margin | -253.98% | -1106.58% | -879.58% | -501.37% | -1178.54% |
Profit Margin | -240.64% | -1071.83% | -776.78% | -478.49% | -1167.58% |
Free Cash Flow Margin | -31119.02% | -1974.78% | -647.54% | -498.43% | -1365.60% |
EBITDA | -15.63 | -30.45 | -30.23 | -35.82 | -12.73 |
EBITDA Margin | -239.77% | - | - | - | - |
D&A For EBITDA | 0.93 | 1.85 | 1.9 | 1.85 | 1.04 |
EBIT | -16.56 | -32.3 | -32.13 | -37.67 | -13.76 |
EBIT Margin | -253.98% | - | - | - | - |